Sanofi Faces China Bribery Probe Over Whistleblower Claims

Law360, New York (August 12, 2013, 2:31 PM EDT) -- Sanofi SA on Monday confirmed that it had been accused by a whistleblower of paying kickbacks to Chinese doctors for prescriptions under the guise of “research grants,” following reports that Chinese officials have launched a probe into the allegations.

The French pharmaceutical giant said in a statement Monday that it was aware of the allegations that it had paid out about 1.7 million yuan ($276,000) in bribes to more than 500 Chinese doctors in late 2007 under the guise of “research grants,” published last week in...
To view the full article, register now.